Kiko “Kla” ta nifiká?
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
Kachó Kardiomiopatia Dilatá Den Welsh Springer Spaniel (DCM-WSS)
Dilated Cardiomyopathy (DCM) in Welsh Springer Spaniels is a serious genetic heart condition that can be detected early through a specialized DNA test. This DNA test identifies specific gene mutations linked to DCM, helping breeders and owners make informed decisions to reduce the risk of this life-threatening disease. Early detection via DNA testing allows for timely veterinary care and management, improving the quality of life for affected dogs. Regular screening of Welsh Springer Spaniels for DCM is essential to maintain a healthy breeding population. Investing in a DCM DNA test supports responsible breeding practices and promotes the long-term health of this beloved breed. Ensure your Welsh Springer Spaniel’s heart health by opting for a reliable DCM DNA test today.
Abreviashon : DCM-WSS
Mutashon analisá : PLN c.26G>A
Herensha : Autosomal Resesivo
Sigla
DCM-WSS
Frekuensha opservá
Severidat klíniko
Klasifikashon klíniko
Malesanan Kardiovaskular
Mutashon analisá
PLN c.26G>A
p.(R9H)
p.(R9H)
Modo di herensia
Autosomal Resesivo
Resumen di prueba:
Dilated Cardiomyopathy (DCM) is a serious heart condition affecting Welsh Springer Spaniels. A DNA test can help identify genetic mutations linked to DCM in this breed. Early detection through testing allows for better management and care. Responsible breeders use DNA tests to reduce the risk of passing DCM to puppies. Regular screening is essential to maintain the health of Welsh Springer Spaniels.
Obtenibel for di e pakete : Basic
E tèst di DNA aki ta inkluí kuminsando for di nos pakete Basic — i tambe ta parti di e paketenan Basic, Standard, Advanced, Complete.
Wak e paketenan di tèst di DNA →Skohe e pakete ku ta pas mihó ku bo strategia di krio òf salú di bo bestianan.
Understanding Dilated Cardiomyopathy (DCM) in Welsh Springer Spaniels
Dilated Cardiomyopathy (DCM) is a serious heart condition that primarily affects the heart muscle, leading to an enlarged heart and reduced ability to pump blood effectively. In Welsh Springer Spaniels, as in other breeds, DCM can have significant implications for the dog's overall health and longevity. Early detection through genetic testing can be a crucial step in managing this condition.
Genetic Basis of DCM
The susceptibility to DCM in Welsh Springer Spaniels is influenced by genetic factors. Research has identified specific mutations associated with DCM, which can lead to the development of the disease. Understanding these genetic markers allows breeders and dog owners to make informed decisions regarding breeding practices and health management.
Symptoms of DCM
Dogs affected by DCM may exhibit a range of symptoms, including lethargy, coughing, difficulty breathing, and decreased exercise tolerance. In some cases, the condition may progress without noticeable signs until it reaches a critical stage. Regular veterinary check-ups and monitoring for any behavioral changes are essential for early intervention.
Importansia di Prueba di DNA
DNA testing plays a vital role in identifying Welsh Springer Spaniels at risk of developing DCM. By screening for known genetic mutations, breeders can make responsible breeding decisions to reduce the prevalence of the disease within the breed. This proactive approach not only benefits individual dogs but also contributes to the overall health of the breed.
Managing DCM in Affected Dogs
For dogs diagnosed with DCM, management is crucial to enhance their quality of life. Treatment may include medications to help support heart function and lifestyle modifications to reduce stress on the heart. Regular veterinary care is essential to monitor the progression of the disease and adjust treatment plans as necessary.
Konklushon
DCM is a significant health concern for Welsh Springer Spaniels, but with advancements in genetic testing and awareness, dog owners and breeders can take proactive steps to manage and reduce the impact of this condition. Understanding the genetic basis, symptoms, and management strategies is essential for promoting the health and well-being of these beloved dogs.
Rasa rekonosé pa e tèst: Kardiomiopatia Dilatá Den Welsh Springer Spaniel (DCM-WSS)
- Welsh Springer Spaniel
🧬 Interpretation of genotypes DCM-WSS
Genotipo
Estado
🟡 N/N
No-transportador - Sin Riesgo
🟡 N/DCM-WSS
Transportadó - Sin Riesgo
❌ DCM-WSS/DCM-WSS
Afektá - Na Riesgo
FAQ: komprondementu di e interpretashon
Un “Transportadó” ta serio?
No. E animal ta generalmente salú pero por transmití e mutashon na su yu.
Kiko si un bestia ta “Afektá”?
E ta karga dos kopia mutá. Ta spera señalnan klíniko dependiendo di e malesa. E no mester wòrdu kriá.
Dikon tin diferensia entre hòmber/muhé?
Algun malesa ta mará na sekso, pues nan ekspreshon ta varia dependiendo di e sekso di bestia.
Pronostiká Desendiente
N/N (no-transportador) )
N/DCM-WSS (Transportador) )
DCM-WSS/DCM-WSS (Afektá) )
FAQ di Prueba di DNA
Kiko e tèst di DNA aki ta detektá?
This DNA test detects the mutation associated with Dilated Cardiomyopathy In Welsh Springer Spaniel (DCM-WSS) in order to identify clear, carrier, or at-risk animals.
Dikon tèst un bestia di krio?
Prueba di DNA ta yuda kriadónan plania parehamentu mas sigur i redusí e riesgo di transmití e mutashon na yunan.
Kiko ta e moda di herensia di e tèst aki?
E moda di herensia raportá pa e tèst aki ta Outosomal Resesivo.
Kua mutashon ta wòrdu analisá den e tèst aki?
This test analyses the mutation PLN c.26G>A.
Un bestia kargadó ta nesesariamente afektá?
No nesesariamente. Interpretashon ta dependé di e patronchi di herensia i e genotipo resultante.
Referensianan
Yost Oriana, Friedenberg Steven G, Jesty Sophy A, Olby Natasha J, Meurs Kathryn M. The R9H phospholamban mutation is associated with highly penetrant dilated cardiomyopathy and sudden death in a spontaneous canine model. Gene. 2019 May 20;697:118-122. doi: 10.1016/j.gene.2019.02.022. Epub 2019 Feb 19.